Abstract:Orodispersible tablet (ODT) is a promising avenue for drug delivery, offering a dosage form that can be disintegrated instantaneously in the mouth and released the drug that dissolves or disperses in the saliva without the addition of water. ODT can effectively boost the dissolution rate and consequently the bioavailability of several hydrophobic drugs. Additionally, ODT is very attractive and suitable for specific patients who are unable to swallow the traditional tablet. The basic approach in the fabrication of oral tablets for hydrophobic drugs relies on the utilization of superdisintegrants which allow prompt disintegration of tablets after swallowing. In the present investigation, escitalopram oxalate was chosen as a model drug, which is a hydrophobic, antidepressant, selective serotonin reuptake inhibitor (SSRI) drug. Nine formulas of escitalopram oxalate ODTs were prepared by varying the concentrations of three different superdisintegrants: sodium starch glycolate, croscarmellose sodium, and crospovidone to improve the dissolution and release of escitalopram oxalate. Each was used in three different concentrations (2.5%, 5%, and 7.5%), and all the ODTs were prepared by the direct compression method. The micrometric characterization of the powder blend used in the formulations was investigated such as angle of repose, bulk and tapped densities, compressibility percent (Carr's index), and Hausner ratio. Furthermore, the prepared ODTs were characterized in terms of weight variation, thickness, diameter, hardness, friability, in vitro disintegration, wetting time, water absorption ratio, drug content, in vitro dissolution, and accelerated stability study. The results showed that the formula (ODT9) that contained 7.5% of the superdisintegrant sodium starch glycolate had superior characteristics in almost all the tests, with a dissolution rate of 100% after 6 minutes. Also, it was stable under the accelerated stability conditions.

Development of a novel direct compressible co-processed excipient and its application for formulation of Mirtazapine orally disintegrating tablets

Development of Multifunctional Directly Compressible Co-processed Orodispersible Excipient Using Spray Drying Technique.

Preparation and Quality Control of Levamlodipine Besylate Orally Disintegrating Tablets

Development and optimization of lyophilized orally disintegrating tablets using factorial design

Overview on Functionality Added Co-processed Excipients for Orodispersible Tablets

Effect of processing methods on xylitol-starch base co-processed adjuvant for orally disintegrating tablet application

Development and Characterization of Multifunctional Directly Compressible Co-processed Excipient by Spray Drying Method

Development and Evaluation of an Orodispersible Tablet Formation for the Delivery of a Hydrophobic Drug

A Novel Lactose/MCC/L-HPC Triple-Based Co-Processed Excipients with Improved Tableting Performance Designed for Metoclopramide Orally Disintegrating Tablets

Co-Processed Chitin-Mannitol as a New Excipient for Oro-Dispersible Tablets

Development and optimization of levodopa and benzylhydrazine orally disintegrating tablets by direct compression and response surface methodology.

A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate

Effect of co-processed excipient type on properties of orodispersible tablets containing captopril, tramadol, and domperidone

Central Composite Designed Fast Dissolving Tablets for Improved Solubility of the Loaded Drug Ondansetron Hydrochloride

Preparation of Lamotrigine Orally Disintegrating Tablets based on the co-processed exicipient

Preparation and Evaluation of Mosapride Citrate Oral Disintegrating Tablets

Application of design of experiments for development and characterization of coprocessed excipients using Lapidium Sativum

Orally disintegrating tablet: A review

Development of Orally Disintegrating Tablets of Perphenazine/hydroxypropyl-β-cyclodextrin Inclusion Complex

Oral disintegrating tablets: best approach for faster therapeutic action of poorly soluble drugs

A dual strategy to improve psychotic patients’ compliance using sustained release quetiapine oral disintegrating tablets